Skip to main content
Premium Trial:

Request an Annual Quote

Zygem Extraction Technology to be Used with Rubicon Kits

NEW YORK (GenomeWeb News) – Zygem and Rubicon Genomics have struck an agreement that will incorporate Zygem's enzymatic nucleic acid extraction technology with Rubicon's pre-analytical platform in an offering aimed at DNA and RNA analysis, Zygem said today.

The integration initially will focus on diagnostic single-cell whole genome amplification kits, but it could expand to include other research and diagnostic products, Zygem said.

The Zygem technology uses a thermophilic enzyme to extract DNA from samples using a closed-tube system, which the company said reduces the time and cost of the extraction process.

Rubicon plans to launch its PicoPlex kits, which integrate the Zygem system into a novel method to amplify single genomes, and is aimed at the genetic diagnostics and cancer diagnostics markets. The product will enable reference labs to begin qPCR, microarray, or sequencing analysis less than three hours after collecting patient cells.

Zygem also noted that the US Patent Office has issued an allowance for an application covering thermophilic enzymes that are used in its nucleic acid extraction technology, and that it expects the patent to be issued later this year.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.